Should You Buy Associated Banc-Corp (ASB) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
Buy now for a beginner long-term investor. ASB is in a constructive uptrend (bullish moving averages, neutral RSI with positive MACD), sentiment from options positioning is notably bullish (very low put/call open interest), and near-term catalysts (dividend, $100M buyback, and announced acquisition) support continued strength. While Wall Street is mostly Neutral/Hold and insiders have been selling more recently, the balance of evidence still favors buying at current levels for a long-term hold, given the improving outlook implied by multiple raised price targets (~$30).
Technical Analysis
Trend is bullish. Price (~26.75–26.77 pre-market) sits near the pivot (26.874). Moving averages are strongly bullish (SMA_5 > SMA_20 > SMA_200), indicating sustained upward momentum. MACD histogram is positive (0.031) but contracting, suggesting upside momentum is still present but cooling. RSI(6) ~51 is neutral (not overbought), leaving room for continuation. Key levels: Support S1 26.079 (then S2 25.589); Resistance R1 27.669 (then R2 28.159). A clean push above ~27.67 would be a bullish continuation signal; a drop below ~26.08 would weaken the setup. Pattern-based projection provided indicates positive odds over 1-week to 1-month horizons (up to ~16.94% in the next month).
Intellectia Proprietary Trading Signals:
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): Entry signal triggered on 2026-01-05; price is up ~1.17% since. This suggests the swing entry was valid and the trade remains constructive; current levels still look acceptable for entry given the ongoing bullish trend structure.
Analyst Ratings and Price Target Trends
Recent trend: price targets have been raised (to ~$30) by Truist, Piper Sandler, RBC Capital, and Keefe Bruyette following Q4 results and a more constructive FY26 outlook; Barclays previously reduced its PT to $30 from $32 in November but maintained an equal-weight type stance. Overall rating posture remains cautious/neutral: Hold/Neutral/Sector Perform/Market Perform dominates rather than Buy.
Wall Street pros: improving net interest income/fees, controlled expenses, stable-to-better credit, healthy C&I loan and deposit trends, and better FY26 outlook driving PT increases.
Wall Street cons: despite better numbers, firms are not upgrading to Buy—suggesting valuation/upside may be more limited or risks remain (macro/credit/expense trajectory).
Politicians/influential figures: No recent congress trading data available in the past 90 days, and no politician/influential trading activity was provided.
Wall Street analysts forecast ASB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASB is 29.71 USD with a low forecast of 29 USD and a high forecast of 32 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast ASB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASB is 29.71 USD with a low forecast of 29 USD and a high forecast of 32 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 26.800
Current: 26.800
